Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125529242 | 12552924 | 2 | F | 2016 | 20160719 | 20160713 | 20160722 | PER | US-SHIRE-US201607456 | SHIRE | 0.00 | F | Y | 64.40000 | KG | 20160722 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125529242 | 12552924 | 1 | PS | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 1 | Oral | 100 MG, 1X/DAY:QD (70 MG AND 30 MG CAPSULE DAILY) | Y | 21977 | 100 | MG | CAPSULE | QD | |||||
| 125529242 | 12552924 | 2 | SS | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 1 | Oral | 70 MG, 1X/DAY:QD | Y | AF4233B | 21977 | 70 | MG | CAPSULE | QD | ||||
| 125529242 | 12552924 | 3 | C | FENTANYL. | FENTANYL | 1 | Transdermal | 25 ?G, OTHER (EVERY 72 HOURS) | 0 | 25 | UG | TRANSDERMAL PATCH | |||||||
| 125529242 | 12552924 | 4 | C | NUCYNTA | TAPENTADOL HYDROCHLORIDE | 1 | Oral | 100 MG, 4X/DAY:QID | 0 | 100 | MG | TABLET | QID | ||||||
| 125529242 | 12552924 | 5 | C | LYRICA | PREGABALIN | 1 | Oral | 150 MG, 2X/DAY:BID | 0 | 150 | MG | TABLET | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125529242 | 12552924 | 1 | Attention deficit/hyperactivity disorder |
| 125529242 | 12552924 | 3 | Pain |
| 125529242 | 12552924 | 4 | Pain |
| 125529242 | 12552924 | 5 | Neuralgia |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125529242 | 12552924 | Adverse event | |
| 125529242 | 12552924 | Appetite disorder | |
| 125529242 | 12552924 | Disturbance in attention | |
| 125529242 | 12552924 | Disturbance in social behaviour | |
| 125529242 | 12552924 | Drug dose omission | |
| 125529242 | 12552924 | Drug effect decreased | |
| 125529242 | 12552924 | Pain | |
| 125529242 | 12552924 | Prescribed overdose | |
| 125529242 | 12552924 | Product quality issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |